To find the right drug for the right target…
go deep
Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented speed and exceptional acumen.
Deep learning that melds technological advances and human expertise…
to mine for new cures in a vast virtual chemical space.
Approach
Deep Apple combines a unique suite of leading technologies from our founders into a powerful deep learning drug discovery engine.
Deep Apple is writing a new playbook for drug discovery. Leveraging a powerful combination of cryo-EM enabled structural biology, AI-powered pocket extraction, molecular dynamics and protein movement modeling, and ultra-high-volume virtual screening of massive, internally generated virtual libraries, Deep Apple’s deep learning approach can quickly identify and advance novel candidates addressing well-validated biological targets for a broad range of diseases.
Since commencing operations in 2022, Deep Apple has rapidly generated a robust and promising pipeline of programs in inflammatory and immune diseases, and metabolic and endocrine disorders.
ATP IS DEVELOPING THE NEXT GENERATION OF TRANSFORMATIVE LIFE SCIENCES COMPANIES.
